Evaluation of peptide COA documentation in practice

In peptide research, even a well-designed experiment can lose its value if the research material is not clearly identified. Therefore, evaluating the COA documentation of peptides is not an extra administrative step. It is the first check whether the vendor's declarations correspond to the specific batch that the laboratory actually receives.

A COA, or Certificate of Analysis, should link the physical vial to measurable analytical data. For products intended solely for scientific purposes, proper reading of the documentation helps to assess whether the material is suitable as an input for in vitro work, analytical comparisons, or methodological research. The mere designation „research quality“ without data is not enough.

What the COA documentation for peptides must demonstrate

A good COA answers three basic questions: what is in the sample, to what extent the declared substance is present, and to which batch the result applies. If the document only contains a general sentence about high quality or a graph without sample identification, its informative value is limited.

In the case of peptides, it is necessary to distinguish between chemical purity, molecular identity and the amount of material. These parameters are related but not interchangeable. For example, the purity of 99 % does not in itself confirm that it is the exact peptide declared. Conversely, the confirmed molecular weight without chromatographic separation does not indicate the proportion of minor components in the sample.

The COA should ideally include the name of the product analyzed, the batch or lot number, the date of analysis, the analytical methods used, the measured results, the pass/fail criteria, and the identification of the laboratory or responsible person. When comparing the document with the packaging, it must be batch number Without this link, it cannot be reliably stated that the submitted certificate belongs to the delivered material.

HPLC Purity: An Important Number, Not the Whole Story

HPLC analysis is one of the most common tools for checking peptide purity. The chromatogram separates the components of the sample according to their interaction with the chromatographic system. With a declared purity of ≥99 %, a dominant main peak and only a minimal proportion of secondary peaks are usually expected within the chosen method.

When reading the result, it is important to note whether the COA states a specific value, such as 99.2 %, or just a vague statement of „>99 %“. A specific value is more transparent, especially if it is clear how it was calculated. In HPLC, purity is typically expressed as the area percentage of peaks at a given detection wavelength. Such a result is very useful, but it is not automatically an absolute mass representation of all impurities.

The chromatogram itself is also important. It should include a time axis, detector signal, integration data and a label for the main peak. An illegible image with no retention, no peak areas or no link to the batch number provides little opportunity for independent assessment. For both short and long peptides, impurities can have similar chromatographic behavior, so HPLC is best evaluated in conjunction with identity confirmation.

What can affect the interpretation of HPLC

Not every chromatogram with a single dominant peak represents an identical analytical standard. The result is affected by the type of column, mobile phase, gradient, detection wavelength, integration method, and sample stability during analysis. Therefore, it is important that the COA at least briefly states the method or analytical conditions used.

When comparing two suppliers, it is not correct to choose only based on the higher percentage after the decimal point. The difference between 99.0 % and 99.4 % may in practice be less significant than the difference between a batch-linked, readable COA with verified identity and a generic document without origin. The context of the experiment and the level of quality control required will determine.

Mass spectrometry confirms identity

Mass spectrometry, often referred to as MS, complements HPLC by verifying the molecular weight of the compound being analyzed. For a peptide, the measured value should correspond to the expected mass of the declared sequence, taking into account the common ion forms and adducts of the technique used.

The COA does not always need to contain complete raw MS data, but should clearly state the expected and observed mass or confirm identity. If only „MS tested“ is listed without a result, this is weaker evidence than data that allows for a meaningful comparison. This layer of control is particularly relevant for compounds where the precise structure is critical to the research question.

However, MS is not a substitute for a purity test. It may confirm the presence of a molecule with the expected mass, but may not quantify all chromatographically separable related substances. It is the combination of HPLC analysis and mass spectrometry that provides a much more convincing picture of batch quality than either result alone.

Batch, date and traceability are not details

A COA without a batch number is a document about an unknown sample. In a laboratory environment, every shipment should be traceable: from the packaging label to the certificate of analysis to internal records of receipt and storage. This discipline will allow you to distinguish whether an unexpected experimental result is related to the biological model, the workflow, or the properties of the input material.

Check that the analysis date is appropriate and that the document does not act as a universal attachment used for all products. An older result is not automatically invalid if it refers to a specific batch and the material was stored correctly. However, more context is needed. Peptides can be sensitive to environmental conditions, so the documentation should be supplemented with clear instructions for product storage and the laboratory team must realistically follow them.

A transparent vendor can provide a batch analysis report upon request or explain what each piece of data means. DoktorPeptid bases its quality control on a declared purity of at least 99 %, HPLC analyses, and the availability of documentation for specific batches. This approach does not preclude in-house laboratory testing, but it gives the researcher a better basis for an informed decision before including the material in the work.

Warning signs when evaluating peptide COA documentation

Not every incomplete document automatically means a poor quality product. Sometimes it is a simplified customer output and a more detailed protocol is available upon request. However, caution is warranted if several deficiencies appear at once:

• The COA does not contain a batch number that matches the product label.
• The name of the analyte, concentration, or size of the analyzed sample is missing.
• Purity is declared without a chromatogram, method, or specific measured value.
• The MS result does not indicate the expected or detected molecular weight.
• The document does not have a date, laboratory identification, or any form of authorization.
• The graphs are repeatedly identical for different batches without explanation.

At the same time, it is important to maintain proportionality. A smaller laboratory may not use the same graphic template as a large contract analytical organization, and a simple COA format alone does not indicate quality. What is essential is whether the document provides auditable, batch-specific data and whether the supplier communicates openly with additional questions.

How to include COA in your own quality control

The COA should be part of the process, not the last attachment in the email. Upon receipt of the shipment, it is a good idea to compare the product and batch identification with the document, record the date of receipt, the condition of the packaging, and set storage according to manufacturer's instructions. For sensitive or long-term projects, the laboratory may consider its own analytical verification, especially if it involves a new source of material, a critical experiment, or results with high decision-making significance.

The extent of verification depends on the nature of the project. For pilot method testing, a thorough review of the batch COA and proper documentation of the handling may be sufficient. For work where maximum reproducibility or comparison between batches is required, it is appropriate to establish more stringent internal criteria, including independent analytical testing. Thus, the COA does not replace professional judgment, but provides data on which to base that judgment.

Good documentation does not just say that the peptide meets the declared parameter. It allows the laboratory to defend the origin of the material, compare batches and work with clear uncertainty limits. Therefore, before starting an experiment, it is worth asking a simple question: can we prove from the available COA what exactly we are holding in our hands? If the answer is not clear, the most reasonable next step is to request additional data.

Related products

Produkty, ktorých sa táto téma týka: Baktériostatická voda – skladom na Slovensku. Ceny a dostupnosť nájdete v sekcii všetky produkty, doplnky ako dávkovacie perá a zvýhodnené balíčky sú v samostatných kategóriách.

Všetky produkty sú určené výhradne na laboratórny výskum.